ARCHIVES

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

This article is from The Cancer Letter archive.

Vol. 06 No. 35 | September 5, 1980

Download PDF Visit The Full Archive

Related Articles

Colorado Center Delays New Core Grant Application

July 13, 1979

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

White House Seek Elimination Of NCI’s Bypass Budget Authority In Legislation Renewing Cancer Act

April 9, 1982

NCI Program: Hughes Institute Official To Head Cancer Biology

July 23, 1999

Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer

September 23, 1994